Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
3301 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
3302 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 36
3303 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 61
3304 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 11
3305 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Germany 61
3306 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb2 Hematology 2022 Standard Therapy Poland 62
3307 Apheresis Allogeneic Myelodysplastic Syndrome Rc Hematology 2022 Standard Therapy Poland 3
3308 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 1 Hematology 2022 Standard Therapy Poland 59
3309 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 2 Hematology 2022 Standard Therapy Poland 67
3310 Apheresis Allogeneic Myelodysplastic Syndrome With Fibrosis Hematology 2022 Standard Therapy Poland 72
3311 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 58
3312 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
3313 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 57
3314 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 64
3315 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 73
3316 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 67
3317 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 66
3318 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
3319 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 60
3320 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 69
3321 Apheresis Allogeneic Myelofibrosis Post Essential Thrombocythemia Hematology 2022 Standard Therapy Poland 64
3322 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 58
3323 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 72
3324 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 73
3325 Apheresis Autologous Myeloma Hematology 2022 Standard Therapy Germany 54
3326 Apheresis Allogeneic Myeloma Multiplex Hematology 2022 Standard Therapy Poland 31
3327 Apheresis Allogeneic Myeloproliferative Neoplasms With Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 59
3328 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 50
3329 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 37
3330 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 64
3331 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 59
3332 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 21
3333 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 38
3334 Apheresis Autologous Nodular Lymphocyte Predominant Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 31
3335 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 73
3336 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 61
3337 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
3338 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 18
3339 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 28
3340 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 55
3341 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 59
3342 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
3343 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
3344 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
3345 Apheresis Allogeneic Other Immune System Hematology 2022 Standard Therapy Poland 46
3346 Apheresis Allogeneic Other Malignancy Hematology 2022 Standard Therapy Poland 72
3347 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 32
3348 Apheresis Allogeneic Plasma Cell Disorder Hematology 2022 Standard Therapy Poland 56
3349 Apheresis Allogeneic Plasma Cell Leukemia Hematology 2022 Standard Therapy Poland 58
3350 Apheresis Allogeneic Post-Essential Thrombocythemia-Myelofibrosis Hematology 2022 Standard Therapy Poland 64
3351 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf)  Hematology 2022 Standard Therapy Poland 48
3352 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
3353 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
3354 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 58
3355 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 39
3356 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 67
3357 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 37
3358 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 69
3359 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 62
3360 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 66
3361 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 70
3362 Apheresis Allogeneic Primary Refractory T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 55
3363 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 58
3364 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 51
3365 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2022 Standard Therapy Poland 53
3366 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2022 Standard Therapy Poland 45
3367 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2022 Standard Therapy Poland 3 months
3368 Apheresis Allogeneic Sezary Syndrome Hematology 2022 Standard Therapy Poland 59
3369 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Poland 6
3370 Apheresis Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 37
3371 Apheresis Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 30
3372 Apheresis Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 46
3373 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
3374 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 51
3375 Apheresis Allogeneic T-Cell Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
3376 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 60
3377 Apheresis Autologous Testicular Cancer Hematology 2022 Standard Therapy Germany 48
3378 Apheresis Allogeneic Thalassemia Major Hematology 2022 Standard Therapy Poland 15
3379 Adipose Tissue Autologous Gonarthrosis Orthopedy 2022 Experimental Therapy Poland 60,11
3380 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2022 Experimental Therapy Poland 41,9
3381 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2022 Experimental Therapy Poland 30,1
3382 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2022 Experimental Therapy Poland 53
3383 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2021 Experimental Therapy Poland 7
3384 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2021 Experimental Therapy Poland 7,8
3385 Cord Tissue Allogeneic – Unrelated Acute Myeloid Leukemia – Transplantation Failure Hematology 2021 Experimental Therapy Poland 13,5
3386 Cord Tissue Allogeneic – Unrelated Ags (Autism + Epilepsy) Neurology 2021 Experimental Therapy Poland 13,3
3387 Cord Tissue Allogeneic – Unrelated Ags (Autism + Epilepsy) Neurology 2021 Experimental Therapy Romania 13
3388 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 74,4
3389 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 64,11
3390 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 70,11
3391 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 59,2
3392 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 47,9
3393 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data
3394 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data
3395 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 66,8
3396 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Experimental Therapy Poland 28,4
3397 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data
3398 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data
3399 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data
3400 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2021 Clinical Trial ALSTEM Poland no data